Postnatal administration of D1 dopamine agonist reverses neonatal dopaminergic lesion-induced changes in striatal enkephalin and substance P systems

Brain Research

Volumn 1073-1074, Issue 1, 2006, Pages 159-163

  Sivam, Subbiah P ^a   Cox, Jeffrey ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

6 Hydroxydopamine; D1 receptor; D2 receptor; Dopamine; LY 171555; Met5 enkephalin; SKF 38393; Substance P

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; METENKEPHALIN; OXIDOPAMINE; QUINPIROLE; SUBSTANCE P; TACHYKININ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; DRUG MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NERVE LESION; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; 3,4-DIHYDROXYPHENYLACETIC ACID; ADRENERGIC AGENTS; ANIMALS; ANIMALS, NEWBORN; CORPUS STRIATUM; DOPAMINE; DRUG INTERACTIONS; ENKEPHALINS; FEMALE; GENE EXPRESSION; HUMANS; MALE; OXIDOPAMINE; PREGNANCY; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SUBSTANCE P;

ANIMALIA;

EID: 33644940357     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.12.076     Document Type: Article

References (36)

1. M.J. Bannon, P.J. Elliot, and E.B. Bunney Striatal tachykinin biosynthesis: regulation of mRNA and peptide levels by dopamine agonist and antagonists Mol. Brain Res. 3 1987 31 37
2. G.J. Baura, and P.D. Walker Stimulated serotonin release from hyperinnervated terminals subsequent to neonatal dopamine depletion regulates striatal tachykinin, but not enkephalin gene expression Mol. Brain Res. 81 2000 80 91
3. G.R. Breese, and T.D. Traylor Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6-hydroxydopamine Br. J. Pharmacol. 44 1972 210 222
4. G.R. Breese, D.J. Knapp, H.E. Criswell, S.S. Moy, S.T. Papadeas, and B.L. Blake The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles Brain Res. Brain Res. Rev. 48 2005 57 73
5. F. Calon, A.H. Tahar, P.J. Blanchet, M. Morissette, R. Grondin, M. Goulet, J.P. Doucet, G.S. Robertson, E. Nestler, T. Di, and P.J. Bedard Dopamine-receptor stimulation: biobehavioral and biochemical consequences Trends Neurosci. 23 2000 S92 S101
6. B.M. Campbell, P.J. Gresch, and P.D. Walker Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamine D1 and serotonin 5HT2 receptors and is targeted to tachykinin neurons of the dorsomedial striatum Neuroscience 105 2001 671 680
7. L.W. Chen, K.K. Yung, and Y.S. Chan Neurokinin peptides and neurokinin receptors as potential therapeutic intervention targets of basal ganglia in the prevention and treatment of Parkinson's disease Curr. Drug Targets. 5 2004 197 206
8. T.M. Engber, R.C. Boldry, S. Kuo, and T.N. Chase Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin Brain Res. 581 1992 261 268
9. P.A. Frohna, B.S. Neal-Beliveau, and J.N. Joyce Neonatal 6-hydroxydopamine lesions lead to opposing changes in the levels of dopamine receptors and their messenger RNAs Neuroscience 68 1995 505 518
10. H.A. Gelbard, M.H. Teicher, R.J. Baldessarini, A. Gallitano, E.R. Marsh, J. Zorc, and G. Faedda Dopamine D1 receptor development depends on endogenous dopamine Brain Res. Dev. Brain Res. 56 1990 137 140
11. C.R. Gerfen Molecular effects of dopamine on striatal-projection pathways Trends Neurosci. 23 2000 S64 S70
12. C.R. Gerfen D1 Dopamine receptor supersensitivity in the dopamine-depleted striatum: animal model of Parkinson's disease Neuroscientist 9 2003 455 462
13. C.R. Gerfen, T.M. Engber, L.C. Mahan, Z. Susel, T.N. Chase, F.J. Monsma, and D.R. Sibley D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons Science 250 1990 1429 1432
14. J. Glowinski, and L.L. Iversen Regional studies of catecholamines in the rat brain: I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain J. Neurochem. 13 1966 655 669
15. R. Granata, G.K. Wenning, J. Jolkkonen, P. Jenner, and C.D. Marsden Effect of repeated administration of dopamine agonists on striatal neuropeptide mRNA expression in rats with a unilateral nigral 6-hydroxydopamine lesion J. Neural Transm. 103 1996 249 260
16. G.R. Hanson, L. Alphs, W. Wolf, R. Levine, and W. Lovenberg Haloperidol-induced reduction of nigral substance P-like immunoreactivity: a probe for the interactions between dopamine and substance P neuronal systems J. Pharmacol. Exp. Ther. 218 1981 568 574
17. J.N. Joyce, P.A. Frohna, and B.S. Neal-Beliveau Functional and molecular differentiation of the dopamine system induced by neonatal denervation Neurosci. Biobehav. Rev. 20 1996 453 486
18. C.D. Kilts, G.R. Breese, and R.B. Mailman Simultaneous quantification of dopamine, 5-hydroxytryptamine and four metabolically related compounds by means of reverse phase HPLC with electrochemical detection J. Chromatogr. Biomed. Appl. 225 1981 347 357
19. S.J. Li, S.P. Sivam, J.F. McGinty, Y.S. Huang, and J.S. Hong Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway J. Pharmacol. Exp. Ther. 243 1987 792 798
20. K.G. Lloyd, O. Hornykiewicz, L. Davidson, K. Shannak, I. Farley, M. Goldstein, H. Shibuya, W.N. Kelley, and I.H. Fox Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome N. Engl. J. Med. 305 1981 1106 1111
21. S.Z. Meng, Y. Ozawa, M. Itoh, and S. Takashima Developmental and age-related changes of dopamine transporter, and dopamine D1 and D2 receptors in human basal ganglia Brain Res. 843 1999 136 144
22. J.A. Obeso, M.C. Rodriguez-Oroz, M. Rodriguez, J.L. Lanciego, J. Artieda, N. Gonzalo, and C.W. Olanow Pathophysiology of the basal ganglia in Parkinson's disease Trends Neurosci. 23 2000 S8 S19
23. P. Salin, G. Dziewczapolski, O.S. Gershanik, A. Nieoullon, and R. Raisman-Vozari Differential regional effects of long-term l-DOPA treatment on preproenkephalin and preprotachykinin gene expression in the striatum of 6-hydroxydopamine-lesioned rat Brain Res. Mol. Brain Res. 47 1997 311 321
24. U.B. Schambra, G.E. Duncan, G.R. Breese, M.G. Fornaretto, M.G. Caron, and R.T. Fremeau Jr. Ontogeny of D1A and D2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding Neuroscience 62 1994 65 85
25. U. Schmidt, C. Beyer, A.B. Oestreicher, I. Reisert, K. Schilling, and C. Pilgrim Activation of dopaminergic D1 receptors promotes morphogenesis of developing striatal neurons Neuroscience 74 1996 453 460
26. S.P. Sivam D1 dopamine receptor-mediated substance P depletion in the striatonigral neurons of rats subjected to neonatal dopaminergic denervation: Implications for self-injurious behavior Brain Res. 500 1989 119 130
27. S.P. Sivam Dopamine-dependent decrease in enkephalin and substance P levels in basal ganglia regions of postmortem parkinsonian brains Neuropeptides 18 1991 201 207
28. S.P. Sivam, and J.E. Krause The adaptation of enkephalin, tachykinin and monoamine neurons of the basal ganglia following neonatal dopaminergic denervation is dependent on the extent of dopamine depletion Brain Res. 536 1990 169 175
29. S.P. Sivam, C. Strunk, D.R. Smith, and J.S. Hong Proenkephalin-A gene regulation in the rat striatum: influence of lithium and haloperidol Mol. Pharmacol. 30 1986 186 191
30. S.P. Sivam, G.R. Breese, J.E. Krause, T.C. Napier, R.A. Mueller, and J.S. Hong Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression J. Neurochem. 49 1987 1623 1633
31. S.P. Sivam, J.E. Krause, G.R. Breese, and J.S. Hong Dopamine-dependent postnatal development of enkephalin and tachykinin neurons of rat basal ganglia J. Neurochem. 56 1991 1499 1508
32. P.D. Walker, and W.A. Wolf Alterations in the postnatal development of striatal preprotachykinin but not preproenkephalin mRNA expression in the serotonin-depleted rat Develop. Neurosci. 19 1997 135 142
33. P.D. Walker, L.A. Riley, R.P. Hart, and G.M. Jonakait Serotonin regulation of neostriatal tachykinins following neonatal 6-hydroxydopamine lesions Brain Res. 557 1991 31 36
34. B.J. Winer Statistical Principles in Experimental Design 1983 McGraw-Hill New York
35. C. Yokoyama, and H. Okamura Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine lesioned rat: 1. Dopaminergic neurons and receptors J. Pharmacol. Exp. Ther. 280 1997 1016 1030
36. W.C. Young III, T.I. Bonner, and M.R. Brann Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain Proc. Natl. Acad. Sci. U. S. A. 83 1986 9827 9831